Polatuzumab Vedotin in the Treatment of Patients with Previously Untreated Diffuse Large B-Cell Lymphoma...
Diffuse large B-cell lymphoma (DLBCL), the most common type of an aggressive form of non-Hodgkin lymphoma (NHL) in the United States and worldwide, is...
Preclinical Study Supports Continued Evaluation of CD25-targeted ADC in Selected Advanced Solid Tumors
Preclinical data for camidanlumab tesirine (formerly ADCT-301; ADC Therapeutics), published in the Journal for ImmunoTherapy of Cancer, the online journal of the Society for...
Modeling and Optimization of Antibody-drug Conjugate Production Using Process Intensified Solid-phase Method
Research article
Abstract
Conventional solution-phase method currently employed for the production of Antibody-drug Conjugates (ADC) has certain drawbacks, which makes production inefficient and cost extensive process....
Confocal Microscopy and Imaging Flow Cytometry – Tools for Selection of Antibodies to be...
Research article
Abstract
Antibody-drug Conjugates (ADCs) are a growing class of targeted anti-cancer therapies, that combine the specific binding of an antibody with the toxic effects...
